New Horizon Capital Joins Series B Round In Cancer Genomics Start-Up Genetron Health

Chinese biotech firm Vcanbio Cell & Gene Engineering Corporation has led a series B round in Genetron Health, a Beijing-based cancer genomics solutions start-up.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

LEAVE A REPLY